Deepika Polineni
Washington University in St. Louis(US)
Publications by Year
Research Areas
Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Tracheal and airway disorders, Pediatric health and respiratory diseases, Family and Disability Support Research
Most-Cited Works
- → Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele(2019)2,037 cited
- → Cystic fibrosis(2021)619 cited
- → Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease(2008)523 cited
- → Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline(2018)468 cited
- → Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes(2021)263 cited
- → Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial(2020)164 cited
- An interactive web-based curriculum on evidence-based medicine: design and effectiveness.(2006)
- → Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci(2019)83 cited
- → Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least oneF508delallele: 144-week interim results from a 192-week open-label extension study(2023)81 cited
- → Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity(2017)61 cited